We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.10 | 9.70 | 10.50 | 10.10 | 10.10 | 10.10 | 177,070 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.83 | 93.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/9/2018 16:22 | wiggy, apologies, it was an oversight, not a deliberate omission: The name calling was started by Inan in his 12:06 post having been baited by tosh ealier that morning. Instead of taking issue with Tosh, Inan launched into everyone (as per usual) Tosh, I didn't want to state the obvious, the figures say it all really. | gazza | |
03/9/2018 16:11 | Well done gaz, you have ignored half of your own process."TF, I think you need to review the thread and:1. Determine the instigator 2. Keep a tally of who is name calling and publish the results" | wigwammer | |
03/9/2018 15:30 | It would appear TF is not interested in the facts. For the record, the Friday "debate" breaks down as follows: Tosh - 1 post, 1 personal/derogatory Dr D - 9 posts, 9 personal/derogatory Lozan - 5 posts, 1 personal/derogatory Gazza - 11 posts, 2 personal/derogatory Inan - 22 posts, 16 personal/derogatory So perhaps TF could address his remarks to the main antagonist or shut up. | gazza | |
03/9/2018 10:52 | wiggy, come on, at least give TF some time to wriggle out of it. | gazza | |
03/9/2018 08:57 | wriggle,wriggle,flap | wigwammer | |
03/9/2018 08:09 | TF, I think you need to review the thread and:1. Determine the instigator 2. Keep a tally of who is name calling and publish the results, not 10% of the results.Come back when you have your facts straight. | gazza | |
03/9/2018 02:55 | Gazza / Ruck aptly named . . You should take a bow M8 - your post 26/4/2018, 751 of 761 on the Richard G Dawson thread :- ''I have revived this thread. Perhaps we could use this one to post about Scancell, the science, the financials, the IP, our different views and opinions and leave the other thread for the exclusive use of those who only want to engage in mindless name-calling and one-upmanship. If someone inadvertently posts the latter here, perhaps we could respectfully remind them and NOT respond in a like manner. I can't be the only one who gets fed up trawling through pages of mindless drivel for the occasional sensible post. What do you think?'' Ah ! That didn't work so NOW, maybe follow your own advice ? But Richard G Dawson - let down again. ATB | torquayfan | |
02/9/2018 14:29 | While it's quiet on the news front - Ira Mellman (Vice President of Research Oncology at Genentech) of CRUK Grand Challenge team Project Blueprint talks (from 16:00) about Biomarkers - which may be of interest to some : | gooosed | |
01/9/2018 13:20 | I see Boom is standing "shoulder To shoulder" with you Lozdob ... lozan unable to "find a friend" brings out his Puppet as a show of solidarity surprised that Gazza has not joined in the celebrations | inanaco | |
01/9/2018 13:05 | Morning Lozan FortunTeky the Astooties will have access to the results soon so we can look at CASH burn something the science anoraks don’t bother with. Mind you with Plums maths he is hardly likely to qualify as an Accou that. Us health professional entrepreneurs cannot only assess the science but skis the Commercuak aspects | drdobson1 | |
31/8/2018 19:05 | the main point Boom was the delay .. was clearly indicated to be ichor in the RNS not saying that my interpretation is indeed correct as we do not know, however it is conceivable and here we are waiting .. | inanaco | |
31/8/2018 18:35 | Thank you Barmooda Shorties to adding your weight shoulder to shoulder to put the Boffoon back in his BOX and highlight the hpgrowing number of Infirmed posters who think he is WRONG | drdobson1 | |
31/8/2018 18:22 | Inanaco, The expiry of the Ichor agreement can't be used as a reason for the delay in the IND. The expiry date of the option has been known since the agreement was signed back in 2016 so there has been plenty of time to plan ahead and negotiate the new agreement. I would have expected them to do that before designing the trial around the Ichor device and before the pre IND meeting with the FDA. I don't believe they could have actually signed the agreement before Ichor's Master File had been cleared by the FDA but it could have been agreed, drafted and just waiting for the green light and there's nothing to suggest it wasn't. | bermudashorts | |
31/8/2018 18:17 | My Dong for baNANA sang to the Tune of the Lsughing policeman. There was a Boffoon by the name of PLUM The share price went down to make him GLUM He cut and paste science to make him appear Bright. In reality he was as useful as a bag of SH1Te. He lost all his money and family and became very sad. His HUGE EGO being the only thing to make him glad. He continues to make us laugh with his pointless utterings. As everyone enjoys kicking him hard to push back his muttering. Hahahahahahahahahaha | drdobson1 | |
31/8/2018 18:06 | Well done Lozan.Done the ex ClOwN up like a kipper. The ifioTt posts yOau are znzoT thinking this through.Never his mistake. He is Full of excuses a swell as SH1Te. CONsuder he is a Plant probably from the PLZUm familyfrom the BOD as he always lays the blame elsewhere. Well if it is proven that baNANA is there to try and deflect t attention away from the BOD Zia am selling up as they are even more complete Idiots to put that Boffoon on charge. Hahahahahahahahahaha Have to come up with a Zsong. | drdobson1 | |
31/8/2018 17:45 | so what common sense would you like to see Loz Tosh sell his shares Gazza sell his shares not sure about Dobson ..as he is your creation ... is he a buyer or seller today ? | inanaco | |
31/8/2018 17:17 | Gazza As you have shown yourself as a blithering idiot ... why do you feel the need to express yourself again ? are you lactating or something, is it hormonal, rather than intellectual .. | inanaco | |
31/8/2018 17:13 | Panama The new batch of SCIB1 has been manufactured successfully and will be released for clinical use in 3Q17. Following the pre-IND meeting held with the FDA in February 2017, we remain on track to submit the IND for a Phase 2 SCIB1/CI combination study in 3Q17. what stopped us ? The Company has been making good progress in compiling the Investigational New Drug (IND) application to the FDA for the SCIB1 checkpoint inhibitor combination study in the US. The request by the FDA for Ichor to provide data on its second generation TriGrid electroporation device has resulted in a short delay to our IND submission. However, we expect that this will be submitted in early 2018. -------------------- again it appeared to over run that RNS ... resulting in the agreement running out so scancell then had to take on the license rather than extending it do you feel that Scancell should have started the trial with that extended agreement expiring mid way through the trial .... ?????? because seriously you are not thinking this through | inanaco | |
31/8/2018 17:06 | Panama, as Inan can't do maths he posts something completely unrelated lol. You don't even need to do the maths anyway if the divisor is bigger and the dividend the same, the quotient will obviously be smaller (sp lower). Alright, here's the maths - £6.67 vs £2.50 | gazza | |
31/8/2018 17:01 | who knows ... i could not predict that Scancell would change to the Ichor ver 2 gun maybe that was forced on to them by Ichor ... ie they would not support the mark 1 gun what we do know, that is why they delayed | inanaco | |
31/8/2018 16:47 | Inanaco, I think you'll find that Chiplin stated in April 2016 that the cash raised would be to enable the Combi trial to commence in 2017 but it hasn't happened has it and we have had 2 further fundraisings and still the trial has not started. Do you think if the trial had started in 2017 and we had some results we would have had to raise funds at 10 & 12p or do you think cash would have been raised significantly higher meaning far less dilution. If the Company was sold for £2bn would the share price be higher with 300m shares in issue or 800m shares in issue. Do the maths. | panama7 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions